Common use of Managed Care Contracts Clause in Contracts

Managed Care Contracts. 6.6.1 The arrangements to assign AstraZeneca's existing managed care contracts to Prometheus (or to AstraZeneca (or its designee) from Prometheus pursuant to Article 20 (Consequences of Termination)) are set out in Schedule J (Transitional Obligations Regarding Managed Market Contracts). 6.6.2 AstraZeneca shall as soon as reasonably practicable following the Effective Date and in any event within ninety (90) days after the Effective Date, withdraw or remove the Product from any AstraZeneca patient assistance programs including the AstraZeneca Together Rx® program and the AstraZeneca Caring Partners program. AstraZeneca shall have the right to continue to distribute the Product in the Territory in connection with such patient assistance programs solely for purposes of fulfilling its obligations that relate directly to orders received under such programs prior to such withdrawal or removal date. In addition, AstraZeneca shall remove the Product from all applicable Medicare contracts within ninety (90) days of the Effective Date. AstraZeneca shall remain liable for all administrative, reporting and related responsibilities up through the date of removal. As of the Effective Date, AstraZeneca shall cease enrolling new patients in the AstraZeneca Patient Assistance program. All patients enrolled in such program on or before the Effective Date, who meet eligibility criteria and adhere to the annual re-enrollment process shall be permitted to remain in such program throughout the Term. Prometheus shall permit AstraZeneca to set aside sufficient Product quantity throughout the Term to enable AstraZeneca to supply Product to program enrollees. AstraZeneca shall not pay Prometheus for such Product and AstraZeneca shall (i) bear all costs associated, or arising in connection, with the AstraZeneca Patient Assistance program, and (ii) remain liable for all administrative, reporting, financial and other responsibilities related to the AstraZeneca Patient Assistance program during and after the Term and Prometheus shall not have any obligations (including any financial obligations) in connection with any such AstraZeneca Patient Assistance program. 6.6.3 Pipeline Inventory adjustment shall be handled by the Parties as set forth in Schedule S (Pipeline Inventory Adjustment Formulas).